No | Rate (%) | |
---|---|---|
Sex | ||
Male | 36 | 64.2 |
Female | 20 | 35.8 |
Age group | ||
10–14 | 5 | 8.9 |
15–18 | 51 | 91.1 |
Presentations | ||
Visual loss | 35 | 62.5 |
Accelerated development | 20 | 35.7 |
Amenorrhoea, galactorrhoea | 16 | 28.6 |
Cushing's disease | 5 | 8.9 |
Headache | 25 | 44.6 |
Extent of adenoma | ||
Intrasellar | 14 | 25 |
Suprasellar extension | 21 | 37.5 |
Cavernous sinus extension | 9 | 16.1 |
Suprasellar and cavernous sinus extension | 12 | 21.4 |